Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-11-05

Clinical Trial Update: First Study of Oral Cysteamine in Cystic Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

The University of Aberdeen conducted a Phase 1/2 clinical trial to evaluate oral cysteamine in individuals with cystic fibrosis, and the study has been complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cysteamine (cysteamine)

Snippet

Sponsor: University of Aberdeen | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED